Nutraplus India Limited Delays September Results Meeting

Nutraplus India Limited adjourned its board meeting for unaudited September 2026 results from 12 November to 14 November 2026 because of a delayed CA report, according to its BSE notice. The deferred meeting is significant because it is expected to consider results for the quarter and half-year ended 30 September 2026.

Why did Nutraplus India Limited defer its September results meeting?

Nutraplus India deferred the directors' meeting originally scheduled for 12 November 2026 to 14 November 2026 due to a delayed CA report. The company disclosed the adjournment through a BSE notice. The supplied information does not specify the nature of the delay beyond the reference to the CA report.

The earlier notice had fixed the board meeting for 3:00 p.m. on 12 November at the company's registered office in Mumbai. The agenda included consideration, approval and adoption of unaudited financial results for the quarter and half-year ended 30 September 2026, together with the Limited Review Report.

The board was also expected to take note of applicable SEBI Listing Obligations and Disclosure Requirements compliance and consider other matters with the chairman's permission. Nutraplus India has not provided the September-quarter financial figures in the supplied disclosures.

A board meeting that considers unaudited results is an important disclosure event for listed companies because the approved numbers, along with the review report where applicable, provide the formal financial update for shareholders and the market. In this case, the reported delay means investors must wait for the rescheduled meeting before assessing the company's September-period performance.

What financial information is currently available for Nutraplus India?

The latest quarterly result stated in the supplied material is Nutraplus India's standalone net profit of ₹0.02 crore for the quarter ended June 2026. This compared with a net loss of ₹0.01 crore in the quarter ended June 2025.

No sales were reported for the June 2026 quarter, and no sales were reported in the corresponding June 2025 quarter. The quarterly-results table also shows revenue of ₹0 crore for June 2025, September 2025, December 2025, March 2026 and June 2026.

For the March 2026 quarter, Nutraplus India reported standalone net profit of ₹0.04 crore, compared with a net loss of ₹0.02 crore in March 2025. Sales were nil in both of those quarters. For the full financial year ended March 2026, the company reported a net loss of ₹0.34 crore, compared with a net loss of ₹0.05 crore in the previous year, while sales remained nil in both years.

What happened at Nutraplus India's 36th annual general meeting?

Nutraplus India held its 36th Annual General Meeting on 30 September 2026, where shareholders approved the audited financial statements for FY2025-26 and the reappointment of Mukesh Naik as director. The meeting was reported as having taken place at 1:05 p.m.

The company subsequently disclosed voting results indicating that all resolutions were approved. The supplied information states that the two cited resolutions received 100% support through e-voting and polling mechanisms. These resolutions covered adoption of the audited FY2025-26 financial statements and the reappointment of Managing Director Mukesh Naik.

The AGM approval followed the close of the financial year ended March 2026, for which the company had reported nil sales and a standalone net loss of ₹0.34 crore. The annual-meeting disclosures therefore established shareholder approval of the audited accounts before the company moved to its September 2026 interim-results cycle.

How does the deferred meeting affect investors and compliance?

The deferred meeting delays the formal board consideration of Nutraplus India's unaudited September 2026 results and associated Limited Review Report. Until those results are approved and disclosed, the supplied material provides no verified update on revenue, profit or loss for the September quarter or the first half of FY2027.

Nutraplus India had earlier announced that its insider-trading window would close from 1 October 2026 and remain closed until 48 hours after the release of the unaudited September-quarter results. This was stated to be in line with SEBI regulations and the company's insider-trading code.

For investors, the reported financial history makes the pending disclosure particularly relevant. The company has reported nil sales across the periods listed in the supplied quarterly table, while small quarterly profit figures were reported for March and June 2026. The upcoming board outcome will be the next disclosed reference point for the September quarter, rather than a basis for assumptions before the official results are released.

Conclusion

Nutraplus India deferred its September 2026 results meeting to 14 November because of a delayed CA report, while its most recently cited quarterly disclosure showed a ₹0.02 crore standalone net profit for June 2026 and nil sales. The company had also completed its 36th AGM, with shareholders approving the FY2025-26 audited accounts and Mukesh Naik's reappointment.

Investors will watch for the board's consideration of unaudited results for the quarter and half-year ended 30 September 2026, the Limited Review Report, and the subsequent results disclosure. The company has stated that its trading window remains closed until 48 hours after the unaudited quarterly results are released.